MedTrace Logo

Memory and Insulin in Early Alzheimer's Disease

NCT00581867 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2015-07-14

Study results available
· View outcomes & findings →

Summary

To determine which parts of the brain are involved in insulin-related memory improvement in early Alzheimer's disease and cognitively normal older adults.

Conditions

Interventions

DRUG

Insulin Aspart

40IU insulin aspart applied intranasally

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Jeff Burns, MD

    lead OTHER

Principal Investigators

  • Jeffrey M Burns, MD · University of Kansas Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00581867 on ClinicalTrials.gov